Simplex Trading
STOK icon

Simplex Trading’s Stoke Therapeutics STOK Stock Holding History

Simplex Trading’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26K Sell
100
-28,400
-100% -$931K ﹤0.01% 8138
2025
Q4 		$905K Buy
28,500
+25,300
+791% +$761K ﹤0.01% 2724
2025
Q3 		$75K Buy
3,200
+900
+39% +$15.4K ﹤0.01% 6058
2025
Q2 		$26K Sell
2,300
-1,600
-41% -$15.2K ﹤0.01% 6543
2025
Q1 		$25K Buy
+3,900
New +$36.4K ﹤0.01% 6408
2024
Q4 		– Sell
-3,800
Closed -$46K – 9577
2024
Q3 		$46K Buy
3,800
+2,000
+111% +$28.3K ﹤0.01% 5956
2024
Q2 		$24K Sell
1,800
-23,200
-93% -$313K ﹤0.01% 6748
2024
Q1 		$337K Buy
+25,000
New +$151K ﹤0.01% 4256
2023
Q3 		– Sell
-100
Closed -$1K – 9776
2023
Q2 		$1K Buy
+100
New +$1.06K ﹤0.01% 8725
2021
Q2 		– Sell
-7
Closed -$27K – 10685
2021
Q1 		$27K Buy
7
+6
+600% +$342 ﹤0.01% 7223
2020
Q4 		$6K Buy
+1
New +$46 ﹤0.01% 7670

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Simplex Trading's STOK Position: Q1 2026 in Review

Simplex Trading reduced its Stoke Therapeutics (STOK) stake by 99% in Q1 2026, selling an estimated $464K and leaving 130 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7998.

Simplex Trading first reported a position in STOK in Q1 2020 and has held it in 18 quarters since. The position peaked at $537K in Q2 2023. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Simplex Trading held 130 shares of Stoke Therapeutics worth $4.23K as of Q1 2026.
  • Simplex Trading sold 14,151 Stoke Therapeutics shares in Q1 2026, an estimated $464K.
  • Stoke Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7998 holding.
  • Simplex Trading first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 18 quarters since.
  • Simplex Trading's Stoke Therapeutics position peaked at $537K in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.